Intracoronary adenosine administered dur
β
Abid R. Assali; Stefano Sdringola; Mohammad Ghani; Ali E. Denkats; Armando Yepes
π
Article
π
2000
π
John Wiley and Sons
π
English
β 49 KB
π 2 views
Percutaneous intervention in acute myocardial infarction has been associated with a high incidence of "no reflow," ranging from 11% to 30%, with an increased risk of complications. The role of intracoronary adenosine for the prevention of this phenomenon has not been evaluated fully. We studied the